Stock listing
HAE Stock Price, News, Filings & Events — Haemonetics Corporation
Selected listing: HAE · NYSE · USD · US
This page tracks Haemonetics Corporation's HAE:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HAE:NYSE. HAE:NYSE is the stock-level entry point for investors researching Haemonetics Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Haemonetics Corporation, trading under the ticker HAE, is a public company based in the United States with a market capitalization of approximately $3.58 billion. The company specializes in blood management solutions, providing products and services that enhance the safety and efficiency of blood collection and transfusion processes. Haemonetics is committed to innovation and improving patient outcomes in healthcare settings.
- Ticker
- HAE:NYSE
- Asset type
- Stock
- Market cap
- $4.73B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NYSE
- Currency
- USD
Haemonetics Corporation HAE:NYSE stock context
This page tracks Haemonetics Corporation's HAE:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HAE:NYSE. HAE:NYSE is the stock-level entry point for investors researching Haemonetics Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Haemonetics Corporation, trading under the ticker HAE, is a public company based in the United States with a market capitalization of approximately $3.58 billion. The company specializes in blood management solutions, providing products and services that enhance the safety and efficiency of blood collection and transfusion processes. Haemonetics is committed to innovation and improving patient outcomes in healthcare settings.
Latest news from Haemonetics Corporation
New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
August 3, 2026
Martin Madaus Elected to Haemonetics Board of Directors
July 28, 2026
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026
July 8, 2026
Haemonetics Updates Financial Reporting Segments
June 5, 2026
Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
Haemonetics Corporation earnings calls
Haemonetics Corporation (HAE) Q1 2027 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Haemonetics Corporation (HAE) Q4 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Haemonetics Corporation (HAE) Q3 2026 Earnings Call
February 5, 2026 · Replay with transcript and chapters
Haemonetics Corporation (HAE) Q2 2026 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Haemonetics Corporation (HAE) Q1 2026 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Haemonetics Corporation (HAE) Q4 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Haemonetics Corporation
Haemonetics Corporation investor report
Review AI stock analysis and investor report context for HAE:NYSE.
Haemonetics Corporation company profile
View the public company page for Haemonetics Corporation on 6ix.
Haemonetics Corporation news
Read company news and market updates connected to Haemonetics Corporation.
Haemonetics Corporation investor events
Find investor webinars, events, and replay context for Haemonetics Corporation.
Alternate listings
HAZ:GETTEX
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
881782:LSX
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
881782:LS
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
HAE:BOATS
US · USD
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
HAZ:TRADEGATE
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
HAZ:DUS
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
HAZ:FWB
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
HAZ:MUN
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.
HAZ:SWB
DE · EUR
Alternate listing for Haemonetics Corporation; the primary context on this page is HAE:NYSE.